By Editor , 31 October 2026
General Dynamics Q3 Revenue Rises 12.9% as Backlog Hits $220.3B

RESTON – October 30, 2026 -- General Dynamics booked $98.8 billion in orders in the third quarter of 2026, a company-wide book-to-bill ratio of 6.8-to-1. Backlog rose to $220.3 billion, while revenue grew 12.9% year over year to $14.6 billion.

Earnings and margin rise across all four segments

Operating earnings reached $1.5 billion, up 14.7% from the year-ago quarter. Diluted earnings per share rose 15.7% to $4.49. Operating margin was 10.5%, a 20-basis-point expansion. Revenue grew in all four segments.

By Editor , 31 October 2026
AAON to Report Q3 2026 Results After Close on Nov. 9

Tulsa – October 30, 2026 -- AAON, Inc. (NASDAQ: AAON), operating as The Aaon Group, will host a conference call and webcast on Monday, November 9, 2026, at 5:00 p.m. EST to discuss its third quarter 2026 financial results.

Results to be released after the market close on November 9

The company will publish its third quarter figures after U.S. market close. The call follows at 5:00 p.m. EST the same day.

By Editor , 31 October 2026
Vail Resorts Board Fights Oasis Slate Ahead of Dec. 14 Vote

BROOMFIELD, Colo. – October 30, 2026 -- Vail Resorts' board is urging shareholders to back all nine of its director nominees and reject four candidates put forward by Oasis Management, arguing the activist slate would put a 17-month turnaround at risk ahead of the Dec. 14, 2026 Annual Meeting of Stockholders.

The NYSE-listed operator (MTN) has filed its definitive proxy statement with the U.S. Securities and Exchange Commission. Holders of record as of Oct. 19, 2026 are entitled to vote. The board is asking for votes on the WHITE proxy card.

By Editor , 31 October 2026
BNCCORP Q3 Net Income Rises 14.7% to $3.0M as Margin Widens

Bismarck – October 30, 2026 -- BNCCORP, INC. (OTCQX: BNCC) reported third-quarter 2026 net income of $3.0 million, or $0.85 per diluted share, up 14.7% from $2.6 million, or $0.74 per share, a year earlier. Excluding ongoing merger charges tied to its pending acquisition by OppFi Inc., net income reached $3.3 million, or $0.94 per diluted share.

By Editor , 31 October 2026

Berlin – October 30, 2026 -- German news broadcaster WELT will run about 32 hours of live special programming around the US midterm elections on November 3 and 4, 2026. Editor-in-chief Helge Fuhst will anchor part of the coverage from a dedicated WELT set at the Capitol in Washington, D.C.

By Editor , 31 October 2026

SAN ANTONIO – October 30, 2026 -- A new national coalition, The Pet Variable, will lobby to have the human-animal bond recognized as a social determinant of health (SDoH) in federal, state and local policy, citing research that up to 70% of American families include a pet.

By Editor , 31 October 2026
SCU Provost: AI Era Demands Stronger Clinical Judgment in Education

WHITTIER, Calif. – October 30, 2026 -- Healthcare education must shift toward critical thinking, clinical judgment and interpersonal skills as AI spreads through care delivery, according to Tamara Rozhon, EdD, Provost of Southern California University of Health Sciences (SCU).

By Editor , 31 October 2026
Cognizant Pools 25,000 Staff Into OpenAI Frontier Group

TEANECK – – October 30, 2026 -- Cognizant (Nasdaq: CTSH) has formed an OpenAI Frontier Capability Group of more than 25,000 professionals dedicated to delivering OpenAI products, including Codex and ChatGPT, to enterprise clients.

The group targets how enterprises write software, serve customers and run daily operations with OpenAI models. Cognizant says model access is no longer the main constraint for many enterprises. The shortage is skilled professionals who can build with those models inside business-critical systems.

By Editor , 31 October 2026
Cambrex Breaks Ground on $120M Iowa Expansion Adding 160,000 Liters

East Rutherford – October 30, 2026 -- Cambrex has started construction on a $120 million expansion at its Charles City, Iowa, facility, adding 160,000 liters of manufacturing capacity for small molecule active pharmaceutical ingredients (APIs) and synthetic peptides.

By Editor , 31 October 2026

Stockholm – October 30, 2026 -- Eisai will present five years of Clarity AD data on lecanemab (Leqembi) at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, November 16-19, 2026, according to its partner BioArctic AB (Nasdaq Stockholm: BIOA B). The dataset spans the core and long-term extension phases and is one of the longest follow-up sets reported to date for an approved anti-amyloid Alzheimer's therapy.